Core Insights - Fortive Corporation has completed the spin-off of its Precision Technologies segment, creating Ralliant Corporation, which began trading on the NYSE under the ticker "RAL" on June 30, 2025 [1][9] - Post-separation, Fortive will focus on Intelligent Operating Solutions and Advanced Healthcare Solutions, while Ralliant will specialize in precision instruments and engineered products [1][2] Company Focus and Strategy - Fortive aims to enhance its recurring revenues and software capabilities, positioning itself for accelerated growth and increased earnings [2][4] - Ralliant is expected to leverage key technology trends to thrive independently [2] Shareholder Impact - Fortive shareholders received one Ralliant share for every three Fortive shares held as of June 16, 2025, totaling around 113 million shares distributed [3] Financial Performance and Challenges - Fortive reported strong fundamentals, including approximately 50% recurring revenues and robust free cash flow, despite facing rising tariff-related pricing pressures and uncertain demand [4][5] - The company anticipates flat to slightly lower revenues, while Ralliant is expected to report a mid-single-digit revenue decline [5] Earnings Guidance - Fortive expects its second-quarter adjusted earnings per share to remain near the midpoint of its prior forecast of 85 cents to 90 cents [6][9] Market Position - Fortive currently holds a Zacks Rank 3 (Hold) and has seen its shares decline by 29.9% over the past six months, contrasting with the Zacks Electronics - Testing Equipment industry's growth of 0.3% [7]
Fortive Finalizes Ralliant Spin-Off, Eyes Growth and Resilience